MARKET

OPGN

OPGN

OpGen
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.290
-0.320
-12.26%
After Hours: 2.260 -0.03 -1.31% 19:51 08/13 EDT
OPEN
2.460
PREV CLOSE
2.610
HIGH
2.490
LOW
2.200
VOLUME
4.40M
TURNOVER
--
52 WEEK HIGH
12.80
52 WEEK LOW
0.9200
MARKET CAP
34.51M
P/E (TTM)
-0.2857
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average OPGN stock price target is 5.00 with a high estimate of 5.00 and a low estimate of 5.00.

EPS

OPGN News

More
OpGen shares are trading lower after the company reported worse-than-expected Q2 sales results.
Benzinga · 12h ago
OpGen, Inc. (OPGN) CEO Oliver Schacht on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 22h ago
OpGen Reports Second Quarter 2020 Financial Results and Provides Business Update
GlobeNewswire · 1d ago
OpGen shares are trading higher after the company reported better-than-expected Q2 EPS results.
Benzinga · 1d ago
OpGen Q2 EPS $(0.49) Beats $(0.51) Estimate, Sales $1.19M Miss $1.20M Estimate
OpGen (NASDAQ:OPGN) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.51) by 3.92 percent. This is a 226.67 percent decrease over losses of $(0.15) per share from the same
Benzinga · 1d ago
The Daily Biotech Pulse: India Globalization Gets Nod For Alzheimer's Trial, Moderna's Vaccine Deal With US, Cellular Biomedicine To Go Private
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11)
Benzinga · 1d ago
A Preview Of OpGen's Earnings
Benzinga · 2d ago
OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers
GlobeNewswire · 2d ago

Industry

Biotechnology & Medical Research
+1.09%
Pharmaceuticals & Medical Research
-0.01%

Hot Stocks

Symbol
Price
%Change

About OPGN

OpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening infections, managing patient outcomes, and the spread of infections caused by multidrug-resistant microorganisms. Its deoxyribonucleic acid (DNA) tests and bioinformatics address the threat of anti-biotic resistance by helping physicians and healthcare providers manage patient care decisions and protect the hospital biome through customized screening and surveillance solutions. It is working to deliver its molecular information solution to a global network of customers and partners. It is also working to provide precise diagnostic information powered by pathogen surveillance data. The Company's high-resolution DNA tests are marketed under the Acuitas trade name.
More

Webull offers kinds of OpGen Inc stock information, including NASDAQ:OPGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPGN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OPGN stock methods without spending real money on the virtual paper trading platform.